psoriasis
PSORIASIS

Psoriasis is a systemic chronic skin disorder characterized by excessive keratinocytes proliferation that results into thickened scaly plaques, itching and inflammatory changes in the epidermis and dermis. It is transmitted genetically but can be provoked by environmental factors.
It is found in approximately 2% of the population that primarily affects the skin and joints.
It is associated with other inflammatory disorders and autoimmune diseases (eg psoriatic arthritis, inflammatory bowel disease, coronary artery disease).
Generally, it begins as red scaling papules that coalesce to form round-to-oval plaques. The rashes are often pruritic and may be painful.

Drug Information

Indication: Moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy....

Indication: Signs & symptoms & inhibiting the progression of structural damage in moderately to severely active rh...

Indication: Prophylaxis of transplant rejection in adult kidney or liver allograft receipients. Kidney or liver allograft ...

Indication: Adult & childn ≥3 mth: Atopic, infantile & discoid eczemas, prurigo nodularis, psoriasis (excluding...

Indication: Relief of inflammatory & pruritic manifestations of steroid-responsive dermatoses eg, psoriasis (excluding...

Indication: Short-term treatment & intermittent long-term therapy of mild to moderate of atopic dermatitis in non-immu...

Indication: Strengthen skin's protective function; increases moisture & lipid content. Reduces feeling of tautness &am...

Indication: Primary immunosuppression in liver & kidney allograft recipients & liver & kidney allograft reject...

Indication: RA; ankylosing spondylitis; psoriatic arthritis; psoriasis; Crohn's & fistulizing Crohn's disease; ulcerat...

Indication: Moderately to severely active Crohn's disease in adult patients who had inadequate response w/, lost response ...

1  /  12
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 13 Jan 2020
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
Stephen Padilla, 6 days ago
The Lancet Commission on Hypertension Group has recently released a position statement that contains a list of recommendations for the improvement of accuracy standards for devices that measure blood pressure (BP).